252 related articles for article (PubMed ID: 22471627)
1. Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway.
Du JX; Sun MY; Du GL; Li FH; Liu C; Mu YP; Chen GF; Long AH; Bian YQ; Liu J; Liu CH; Hu YY; Xu LM; Liu P
BMC Complement Altern Med; 2012 Apr; 12():33. PubMed ID: 22471627
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation.
Yongping M; Zhang X; Xuewei L; Fan W; Chen J; Zhang H; Chen G; Liu C; Liu P
J Ethnopharmacol; 2015 Jul; 169():200-9. PubMed ID: 25917841
[TBL] [Abstract][Full Text] [Related]
4. [Huangqi decoction inhibits cholangiocyte proliferation and transdifferentiation in cholestatic liver fibrosis induced by BDL in rats].
DU JX; Qiu BF; Liu P; Sun MY; Chen GF; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):13-8. PubMed ID: 20128962
[TBL] [Abstract][Full Text] [Related]
5. JinSanE decoction, a chinese herbal medicine, inhibits expression of TGF-beta1/Smads in experimental hepatic fibrosis in rats.
Song SL; Gong ZJ; Huang YQ; Zhang QR; Huang TX
Am J Chin Med; 2006; 34(6):1047-61. PubMed ID: 17163593
[TBL] [Abstract][Full Text] [Related]
6. Huang Qi Decoction Prevents BDL-Induced Liver Fibrosis Through Inhibition of Notch Signaling Activation.
Zhang X; Xu Y; Chen JM; Liu C; Du GL; Zhang H; Chen GF; Jiang SL; Liu CH; Mu YP; Liu P
Am J Chin Med; 2017; 45(1):85-104. PubMed ID: 28081630
[TBL] [Abstract][Full Text] [Related]
7. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
[TBL] [Abstract][Full Text] [Related]
8. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
9. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol suppresses cholestasis-induced liver injury and fibrosis in rats associated with the inhibition of TGFβ1-Smad3-miR21 axis and profibrogenic and hepatic injury biomarkers.
ShamsEldeen AM; Al-Ani B; Ebrahim HA; Rashed L; Badr AM; Attia A; Farag AM; Kamar SS; Haidara MA; Al Humayed S; Ali Eshra M
Clin Exp Pharmacol Physiol; 2021 Oct; 48(10):1402-1411. PubMed ID: 34157155
[TBL] [Abstract][Full Text] [Related]
11. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
Song SL; Gong ZJ; Zhang QR; Huang TX
World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats.
Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ
J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498
[TBL] [Abstract][Full Text] [Related]
13. Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.
Wu L; Zhou PQ; Xie JW; Zhu R; Zhou SC; Wang G; Wu ZX; Hao S
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):519-524. PubMed ID: 26223920
[TBL] [Abstract][Full Text] [Related]
14. Effects of Haobie Yangyin Ruanjian decoction on hepatic fibrosis induced by carbon tetrachloride in rats.
Yang FR; Fang BW; Lou JS
World J Gastroenterol; 2010 Mar; 16(12):1458-64. PubMed ID: 20333785
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of rutin on liver injury induced by biliary obstruction in rats.
Pan PH; Lin SY; Wang YY; Chen WY; Chuang YH; Wu CC; Chen CJ
Free Radic Biol Med; 2014 Aug; 73():106-16. PubMed ID: 24815012
[TBL] [Abstract][Full Text] [Related]
16. Effect of ursodeoxycholic acid on TGF beta1/Smad signaling pathway in rat hepatic stellate cells.
Liang TJ; Yuan JH; Tan YR; Ren WH; Han GQ; Zhang J; Wang LC; Qin CY
Chin Med J (Engl); 2009 May; 122(10):1209-13. PubMed ID: 19493473
[TBL] [Abstract][Full Text] [Related]
17. TGFβ1-Smad Signaling Pathway Participates in Interleukin-33 Induced Epithelial-to-Mesenchymal Transition of A549 Cells.
Tan QY; Cheng ZS
Cell Physiol Biochem; 2018; 50(2):757-767. PubMed ID: 30308508
[TBL] [Abstract][Full Text] [Related]
18. EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling.
Park SA; Kim MJ; Park SY; Kim JS; Lee SJ; Woo HA; Kim DK; Nam JS; Sheen YY
Cell Mol Life Sci; 2015 May; 72(10):2023-39. PubMed ID: 25487606
[TBL] [Abstract][Full Text] [Related]
19. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
Wu N; Meng F; Invernizzi P; Bernuzzi F; Venter J; Standeford H; Onori P; Marzioni M; Alvaro D; Franchitto A; Gaudio E; Glaser S; Alpini G
Hepatology; 2016 Sep; 64(3):865-79. PubMed ID: 27115285
[TBL] [Abstract][Full Text] [Related]
20. Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor‑β/Smad pathway in rats.
Huang W; Li L; Tian X; Yan J; Yang X; Wang X; Liao G; Qiu G
Mol Med Rep; 2015 Feb; 11(2):805-14. PubMed ID: 25373883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
